Vijay Dhondge has more than 22 years of experience in Medicinal Chemistry, CDMO and Operations. He has a key expertise in Drug Discovery, Process Research, Product Development and Technology Transfer and cGMP Manufacturing. He co-authored over 20 publications, patents and articles. He developed IND molecule in antibacterial area-oxazolidinone, Fluoroquinolones and Efflux.

Vijay D. Dhondge Senior VP, CRO, CDMO and Operations


Speak With Expert

LAXAI supports customers achieve their Goals by strong emphasis on Safety, Quality, Reliability, Innovation and Efficiency by combining World Class Research Talent and Infrastructure with Cost Advantage.